Product Line Sales
The following table summarizes the Company’s sales by major product lines (dollars in thousands):
|Three Months Ended|
|September 27,||September 28,||%||June 28,||%|
|Total Implantable Medical||129,338||121,093||7%||128,604||1%|
Cardiac and neuromodulation sales for the third quarter of 2013 increased 8% compared to the prior year to $87.0 million. This increase was driven by stronger market performance and continued deepening relationships with our OEM partners. More specifically, during the quarter we experienced double digit growth in medical batteries, capacitors, leads and feedthroughs. We continue to see an increased pace of product development opportunities from our cardiac customers. We believe that these opportunities, combined with our increased sales and marketing resources, will allow the Company to continue to grow this product line faster than the underlying market.